JP2022521173A5 - - Google Patents

Info

Publication number
JP2022521173A5
JP2022521173A5 JP2021547154A JP2021547154A JP2022521173A5 JP 2022521173 A5 JP2022521173 A5 JP 2022521173A5 JP 2021547154 A JP2021547154 A JP 2021547154A JP 2021547154 A JP2021547154 A JP 2021547154A JP 2022521173 A5 JP2022521173 A5 JP 2022521173A5
Authority
JP
Japan
Application number
JP2021547154A
Other languages
Japanese (ja)
Other versions
JP2022521173A (ja
JPWO2020165181A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/053490 external-priority patent/WO2020165181A1/en
Publication of JP2022521173A publication Critical patent/JP2022521173A/ja
Publication of JPWO2020165181A5 publication Critical patent/JPWO2020165181A5/ja
Publication of JP2022521173A5 publication Critical patent/JP2022521173A5/ja
Priority to JP2025162216A priority Critical patent/JP2026016402A/ja
Withdrawn legal-status Critical Current

Links

JP2021547154A 2019-02-12 2020-02-11 癌治療 Withdrawn JP2022521173A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025162216A JP2026016402A (ja) 2019-02-12 2025-09-29 癌治療

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP19156806 2019-02-12
EP19156806.2 2019-02-12
EP19176575 2019-05-24
EP19176575.9 2019-05-24
PCT/EP2020/053490 WO2020165181A1 (en) 2019-02-12 2020-02-11 Cancer treatment

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025162216A Division JP2026016402A (ja) 2019-02-12 2025-09-29 癌治療

Publications (3)

Publication Number Publication Date
JP2022521173A JP2022521173A (ja) 2022-04-06
JPWO2020165181A5 JPWO2020165181A5 (https=) 2023-02-21
JP2022521173A5 true JP2022521173A5 (https=) 2023-02-21

Family

ID=69467563

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021547154A Withdrawn JP2022521173A (ja) 2019-02-12 2020-02-11 癌治療
JP2025162216A Pending JP2026016402A (ja) 2019-02-12 2025-09-29 癌治療

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025162216A Pending JP2026016402A (ja) 2019-02-12 2025-09-29 癌治療

Country Status (16)

Country Link
US (1) US20220168298A1 (https=)
EP (1) EP3923942A1 (https=)
JP (2) JP2022521173A (https=)
KR (1) KR20210126654A (https=)
CN (1) CN113423402A (https=)
AU (1) AU2020223467B2 (https=)
BR (1) BR112021015686A2 (https=)
CA (1) CA3126959A1 (https=)
IL (1) IL285466A (https=)
JO (1) JOP20210216A1 (https=)
MA (1) MA54932A (https=)
MX (1) MX2021009670A (https=)
PH (1) PH12021551949A1 (https=)
SG (1) SG11202107850VA (https=)
TW (1) TWI863962B (https=)
WO (1) WO2020165181A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023553533A (ja) * 2020-12-11 2023-12-21 エラスカ,インク. 癌の処置のための併用療法
CN117083283A (zh) * 2020-12-11 2023-11-17 医睿世康药业研发公司 用于癌症治疗的联合疗法
CN112957368A (zh) * 2021-04-02 2021-06-15 南昌大学 一种司维拉姆的新用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4063516A1 (en) * 2014-09-26 2022-09-28 Janssen Pharmaceutica NV Use of fgfr mutant gene panels in identifying cancer patients that will be responsive to treatment with an fgfr inhibitor
TWI719960B (zh) * 2015-02-10 2021-03-01 英商阿斯迪克治療公司 新穎組成物
AU2016341445B2 (en) * 2015-10-23 2020-08-27 Array Biopharma, Inc. 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases
AU2018216969B2 (en) * 2017-02-06 2024-04-11 Janssen Pharmaceutica Nv Cancer treatment
JOP20190280A1 (ar) * 2017-06-02 2019-12-02 Janssen Pharmaceutica Nv مثبطات fgfr2 لعلاج سرطان الأوعية الصفراوية
MA47408B1 (fr) * 2017-12-20 2023-08-31 Janssen Pharmaceutica Nv Traitement du cancer

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
JP2023553533A5 (https=)
BR112021017747A2 (https=)
JP2022521173A5 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)